Achieve Reports Financial Results for Second Quarter 2019 and Provides Cytisinicline Clinical Development Update

Go back to Achieve Reports Financial Results for Second Quarter 2019 and Provides Cytisinicline Clinical Development Update

Achieve Life Sciences (ACHV) Tops Q2 EPS by 6c

August 8, 2019 4:39 PM EDT

Achieve Life Sciences (NASDAQ: ACHV) reported Q2 EPS of ($0.50), $0.06 better than the analyst estimate of ($0.56).

For earnings history and earnings-related data on Achieve Life Sciences (ACHV) click here.

... More